Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2000
11/28/2000US6153182 Lymphotactin as an adjuvant
11/28/2000US6153171 Methods for identifying compounds effective for treating neurodegenerative disorders and for monitoring the therapeutic intervention therefor
11/28/2000US6153129 Production scale method of forming microparticles
11/28/2000US6152897 Bi-compartment, one-dose syringe comprising a first chamber containing freeze dried mixture of growth hormone, mannitol and an amino acid and a second chamber containing an injectable aqueous reconstitution solution; storage stability
11/28/2000CA2309520A1 Compositions for stabilizing oxygen-labile species
11/28/2000CA2308259A1 Method for assaying the function of flaa1 and wbpm
11/28/2000CA2305716A1 Method for assay of wbpm
11/28/2000CA2182970C Lyophilized stem cell factor formulations
11/28/2000CA2137348C Synthetic peptide lung surfactants having covalently bonded antioxidants
11/28/2000CA2127199C Prevention and treatment of ischemic events and reperfusion injury resulting therefrom
11/28/2000CA2085037C Stabilized pharmaceutical compositions comprising an hmg-coa reductase inhibitor compound
11/28/2000CA2066428C Structural alterations of the egf receptor gene in human gliomas
11/27/2000CA2310218A1 A composition and method for treating bacterial infection
11/23/2000WO2000070665A2 Long lasting anti-angiogenic peptides
11/23/2000WO2000070341A2 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer
11/23/2000WO2000070099A2 Differential gene expression in specific regions of the brain in neurodegenerative diseases
11/23/2000WO2000070092A1 Expression of ets-domain proteins in cancer
11/23/2000WO2000070091A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF HUMAN PROTEIN KINASE C-δ EXPRESSION
11/23/2000WO2000070086A1 Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms
11/23/2000WO2000070076A1 Tm4sf receptors
11/23/2000WO2000070075A1 STREPTOCOCCUS PNEUMONIAE yerS
11/23/2000WO2000070051A1 NEUROPROTECTIVE PROPERTIES OF GDF-15, A NOVEL MEMBER OF THE TGF-β SUPERFAMILY
11/23/2000WO2000070050A1 Compositions and methods for the treatment of immune related diseases
11/23/2000WO2000070049A2 Extracellular signaling molecules
11/23/2000WO2000070047A2 Full-length molecules expressed in human tissues
11/23/2000WO2000070046A2 Secreted polypeptides and corresponding polynucleotides
11/23/2000WO2000070045A1 Ox2 receptor homologs
11/23/2000WO2000070043A1 Recombinant human mannan-binding lectin
11/23/2000WO2000070042A1 143 human secreted proteins
11/23/2000WO2000070036A2 Genes expressed in hippocampus
11/23/2000WO2000070035A1 Inhibitors for viral infection targeting integrase n-terminal region
11/23/2000WO2000070034A1 Instant formulations of enzymes, used for animal feed
11/23/2000WO2000070028A1 Sphingosine kinase enzyme
11/23/2000WO2000070025A1 Methods of using rnase p reaction mechanisms of action
11/23/2000WO2000070024A2 Infectious retroviruses from a leukemic dog cell line with extensive homologies to murine leukemia viruses
11/23/2000WO2000070017A2 Methods using of fab i and compounds modulating fab i activity
11/23/2000WO2000069914A2 Humanized antibodies specific for egp-2
11/23/2000WO2000069913A1 EXPRESSION AND EXPORT OF INTERFERON-ALPHA PROTEINS AS Fc FUSION PROTEINS
11/23/2000WO2000069911A1 Long lasting insulinotropic peptides
11/23/2000WO2000069910A1 Chemokine-like factors having cell chemokinesis function and proliferation-stimulating activity
11/23/2000WO2000069909A1 Isolation and characterization of epidermal growth factor related protein
11/23/2000WO2000069908A1 Interaction between the vhl tumour suppressor and hypoxia inducible factor, and assay methods relating thereto
11/23/2000WO2000069904A1 LAWSONIA DERIVED GENE AND RELATED FlgE POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES
11/23/2000WO2000069903A1 LAWSONIA DERIVED GENE AND RELATED SodC POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES
11/23/2000WO2000069902A1 Long lasting fusion peptide inhibitors or viral infection
11/23/2000WO2000069901A2 Proteins with insulin-like activity useful in the treatment of diabetes
11/23/2000WO2000069900A2 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
11/23/2000WO2000069898A2 Molecular interactions in allergy cells
11/23/2000WO2000069897A2 Modulation of glgf motif (dhr/pdz) containing proteins interaction with cd3n in t lymphocytes
11/23/2000WO2000069896A2 Molecular interactions in haematopoietic cells
11/23/2000WO2000069895A2 Bufornin 1 as a specific inhibitor and therapeutic agent for botulinum toxin b and tetanus neurotoxins
11/23/2000WO2000069894A2 Novel indications of mannan-binding lectin (mbl) in the treatment of immunocompromised individuals
11/23/2000WO2000069893A1 Glycopeptide antibacterial compounds, compositions containing same and methods of using same
11/23/2000WO2000069892A1 Glycopeptide antibiotics, combinatorial libraries of glycopeptide antibiotics and methods of producing same
11/23/2000WO2000069891A2 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins
11/23/2000WO2000069890A1 Prevention of dental caries
11/23/2000WO2000069889A1 Phosphonic and carboxylic acid derivatives as inhibitors of protein tyrosine phosphatase-1b (ptp-1b)
11/23/2000WO2000069888A1 Self-assembling biomolecular structures
11/23/2000WO2000069887A2 Rapid dehydration of proteins
11/23/2000WO2000069884A2 Compositions isolated from skin cells and methods for their use
11/23/2000WO2000069879A2 Ca7 cg04 gene
11/23/2000WO2000069873A1 Trmd
11/23/2000WO2000069472A2 Enzyme-activated anti-tumor prodrug compounds
11/23/2000WO2000069463A1 Compositions and methods for treating cell proliferation disorders
11/23/2000WO2000069457A1 Protein a based binding domains with desirable activities
11/23/2000WO2000069456A2 Adjuvant combination formulations
11/23/2000WO2000069454A1 Suppression of endogenous igfbp-2 to inhibit cancer
11/23/2000WO2000069450A1 Oncogene identification by transformation of rk3e cells and uses thereof
11/23/2000WO2000069449A2 Conditioned cell culture medium compositions and methods of use
11/23/2000WO2000069428A2 Anionic polymers as toxin binders and antibacterial agents
11/23/2000WO2000069427A1 Composition and method for treating limb ischemia
11/23/2000WO2000069425A2 Endoparasiticidal synergistic combination containing cyclic depsipeptides and piperazines
11/23/2000WO2000069412A1 Method of treating angina and/or anginal equivalents, and pharmaceutical compositions and kit related thereto
11/23/2000WO2000069262A1 NOVEL β-SECRETASE AND MODULATION OF β-SECRETASE ACTIVITY
11/23/2000WO2000069256A1 Transgenically produced antithrombin iii and mutants thereof
11/23/2000WO2000069255A1 Anti-inflammatory therapy for inflammatory mediated infection
11/23/2000WO2000048618A8 Method of preventing and treating symptoms of aging and neurodegenerative dysfunctions with relaxin
11/23/2000WO2000046245A3 Human antibiotic proteins
11/23/2000WO2000040615A3 EXPRESSION AND EXPORT OF ANTI-OBESITY PROTEINS AS Fc FUSION PROTEINS
11/23/2000WO2000038706A3 Methods for treating cancer and for mediating chemotaxis of dendritic cells
11/23/2000WO2000037685A9 Method of identifying a psychotropic agent using differential gene expression
11/23/2000WO2000037608A3 Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto
11/23/2000WO2000037502A3 Vascular endothelial cell growth factor antagonists and uses thereof
11/23/2000WO2000037067A9 Sensitizing agents for the treatment of skin lesions
11/23/2000WO2000036918A9 Methods and compositions for treatment of cell proliferative disorders
11/23/2000WO2000036910A9 Msh5 ablated mice and uses therefor
11/23/2000WO2000036124A3 Plant cell cycle genes and uses thereof
11/23/2000WO2000036092A3 METHOD FOR THE HIGH LEVEL EXPRESSION OF ACTIVE LYMPHOTOXIN-β RECEPTOR IMMUNOGLOBULIN CHIMERIC PROTEINS AND THEIR PURIFICATION
11/23/2000WO2000032221A3 Promotion or inhibition of angiogenesis and cardiovascularization
11/23/2000WO2000031242A3 Engineered cytotoxic ribonuclease
11/23/2000WO2000031124A3 Peptides that modulate the interaction of b class ephrins and pdz domains
11/23/2000WO2000030681A9 Antagonists of the alpha e beta 7 integrin as therapeutic agents for inflammatory diseases
11/23/2000WO2000029556A3 Identification of glycosphingolipids that promote hiv-1 entry into cells
11/23/2000WO2000028031A3 Mitogenic regulators
11/23/2000WO2000028013A3 Gene expression modulated by activation of microglia or macrophages
11/23/2000WO2000027994A3 Chlamydia pneumoniae genome sequence
11/23/2000WO2000027429A3 Vaccine against papillomatous digital dermatitis (pdd)
11/23/2000WO2000027423A3 Methods and compositions for treating common cold symptoms
11/23/2000WO2000026357A3 Transgenic and cloned mammals
11/23/2000WO2000026348A3 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity
1 ... 2321 2322 2323 2324 2325 2326 2327 2328 2329 2330 2331 2332 2333 2334 2335 2336 2337 2338 2339 2340 2341 ... 3163